Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-022075
Filing Date
2016-08-02
Accepted
2016-08-02 16:16:07
Documents
48
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vtvt-10q_20160630.htm 10-Q 1068357
2 EX-31.1 vtvt-ex311_9.htm EX-31.1 16201
3 EX-31.2 vtvt-ex312_8.htm EX-31.2 16093
4 EX-32.1 vtvt-ex321_6.htm EX-32.1 7258
5 EX-32.2 vtvt-ex322_7.htm EX-32.2 7213
6 GRAPHIC gfrff0nap0rk000001.jpg GRAPHIC 20442
  Complete submission text file 0001564590-16-022075.txt   3248717

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vtvt-20160630.xml EX-101.INS 402955
8 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20160630.xsd EX-101.SCH 34007
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20160630_cal.xml EX-101.CAL 30908
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20160630_def.xml EX-101.DEF 122172
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20160630_lab.xml EX-101.LAB 250957
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20160630_pre.xml EX-101.PRE 193858
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 161800668
SIC: 2834 Pharmaceutical Preparations